GlobeNewsWire · RVMD · October 23, 2026

Revolution Medicines Presents Overall Survival Data for RASONQUE™ (daraxonrasib) Across Subgroups in Previously Treated Metastatic Pancreatic Cancer at ESMO 2026

Get the app for more

Explore stock news, insights and company research.